Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells
Tamoxifen (TAM) is the mainline drug treatment for breast cancer, despite its side effects and the development of resistance. As an alternative approach, in the present study a novel combination therapy was established through combining TAM with nordamnacanthal (NDAM) in order to investigate the add...
| Published in: | Oncology Letters |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Spandidos Publications
2015
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84911416710&doi=10.3892%2fol.2014.2697&partnerID=40&md5=e9c09327a47d2497d5cb71311b6a7a3f |